|
CNBC'S MOST SHARED
- WPP's Sir Martin Sorrell on the Ad Recession
- Unemployed? Bored? Make Money Playing Beer Pong
- Social Networking's 'Naked' Truth
- Merrill's McCann Seen as UBS Wealth Frontrunner
- The View From Newark
- Warren Buffett's Top Three Investment Rules for the Average American
- Eric Schmidt on Government Scrutiny and Economic Recovery
- Roginsky: No More Mr. Nice Guy
- Why You Should Watch Fund Flows
- Warren Buffett's Complete Sun Valley CNBC Interview - Transcript and Video
- Buffett's Top 3 Investment Rules for Average Americans
- Market Insider: Earnings Loom in the Week Ahead
- White House Weighing Assistance for Small Businesses
- How Serious Is White House About Second Stimulus?
- Bulls Get Summertime Blues, But It's Hot Fun for Bears
- As Banks Fail, Strong Institutions Become More Visible
- Merrill's McCann Seen as UBS Wealth Frontrunner
- It's Not the Wealthy Who Are Leaving California: Study
- Atlantic City Takes Hit as Pennsylvania Casino Opens
- Eric Schmidt on Government Scrutiny and Economic Recovery
- Market 360: The Week's Best & Worst
- Geek Squad V. Gizmodo
- Brandt: Google Chrome OS in the Post-PC Age
- Other People Are Weirder Than We Are
- Bank Failures: Is The Nightmare Over? (Video)
- California Here I Go? No.
- Roginsky: No More Mr. Nice Guy
- Commercial Conundrum
Text Size 
A first-of-its-kind study suggests that allergic reactions to the popular vaccine for cervical cancer are rare and can often be overcome.
Australian researchers report in the new issue of the "British Medical Journal" that hypersensitivity to the shots is uncommon and that most girls who do have a reaction can later go on to get the shots with no serious side effects. The doctors recommend that more studies be done, however.
Last year Australia started requiring adolescent schoolgirls to get the vaccine for the human papillomavirus (HPV), the sexually transmitted infection that is the leading cause of cervical cancer. After more than 380,000 doses were administered, 35 girls were identified as having had some kind of reaction. The problems included rash, hives and in two patients a more severe, widespread allergic response.
The BMJ study is being published close on the heels of a recent report out of the U.S. Centers for Disease Control that concluded there's no evidence that Gardasil has serious side effects.
Merck [MRK
Loading...
()
] sells the vaccine, Gardasil, in the United States. GlaxoSmithKline [GSK
Loading...
()
] is awaiting FDA approval on a similar product called Cervarix. The Australian researchers say the Merck shots may have ingredients that could be causing the small number of allergic reactions and that the GSK vaccine, which is made differently, could be an alternative for some girls.
Print
Email
Data is a real-time snapshot *Data is delayed at least 15 minutes